Utama › Kanser Esofagus
Kajian klinikal Kanser Esofagus sedang mengambil peserta di AS
110 kajian untuk Kanser Esofagus sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX36 kajian
- Boston, MA23 kajian
- New York City, NY22 kajian
- Nashville, TN19 kajian
- St. Louis, MO17 kajian
- Pittsburgh, PA15 kajian
- Los Angeles, CA15 kajian
- Grand Rapids, MI14 kajian
- Baldwin Park, CA14 kajian
- Philadelphia, PA13 kajian
- San Antonio, TX12 kajian
- Dallas, TX11 kajian
- Chicago, IL11 kajian
- Arlington, VA11 kajian
- Rochester, MN11 kajian
- San Diego, CA10 kajian
- Durham, NC10 kajian
- Cleveland, OH10 kajian
- Portland, OR10 kajian
- Washington, DC9 kajian
- Atlanta, GA9 kajian
- Denver, CO9 kajian
- Detroit, MI9 kajian
- Birmingham, AL8 kajian
- Orlando, FL8 kajian
- Milwaukee, WI8 kajian
- Tampa, FL8 kajian
- Minneapolis, MN8 kajian
- Indianapolis, IN8 kajian
- Toledo, OH7 kajian
- Aurora, CO7 kajian
- Edison, NJ7 kajian
- Santa Monica, CA7 kajian
- Seattle, WA7 kajian
- Mountain View, CA7 kajian
- Salt Lake City, UT7 kajian
- Baltimore, MD7 kajian
- Kansas City, MO7 kajian
- Columbus, OH7 kajian
- Queens, NY6 kajian
Mengikut negeri
- Alabama8 kajian
- Alaska4 kajian
- Arizona11 kajian
- Arkansas6 kajian
- California41 kajian
- Colorado19 kajian
- Connecticut8 kajian
- Delaware3 kajian
- Florida33 kajian
- Georgia11 kajian
- Idaho3 kajian
- Illinois15 kajian
- Indiana12 kajian
- Iowa6 kajian
- Kansas8 kajian
- Kentucky8 kajian
- Louisiana5 kajian
- Maine3 kajian
- Maryland13 kajian
- Massachusetts25 kajian
- Michigan22 kajian
- Minnesota19 kajian
- Missouri20 kajian
- Montana4 kajian
- Nebraska7 kajian
- New Jersey9 kajian
- New Mexico6 kajian
- New York28 kajian
- North Carolina16 kajian
- North Dakota4 kajian
- Ohio22 kajian
- Oklahoma8 kajian
- Oregon11 kajian
- Pennsylvania29 kajian
- Rhode Island3 kajian
- South Carolina7 kajian
- South Dakota4 kajian
- Tennessee21 kajian
- Texas46 kajian
- Utah8 kajian
- Virginia16 kajian
- Washington11 kajian
- West Virginia3 kajian
- Wilayah Columbia4 kajian
- Wisconsin16 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00242723Distance-Based Exercise to Preserve Function and Prevent Disability
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07283939A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05319730Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06265285Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07090499A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07814248A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07578571Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07603375Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07519655DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06123338Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379Pan-tumor MRD Study
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06605404sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05332002Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213791Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432Prehabilitation in High-risk Oncologic Surgery
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07638410Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07217704Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.